Dr Jennifer Snaith is Post-doctoral Scientist at the Victor Chang Cardiac Research Institute and Staff Specialist Endocrinologist who leads the Diabetes in Youth service at St Vincent’s Hospital, Sydney. She is group co-lead of the Australian Collaborative Towards Adjunctive Therapies in Type 1 Diabetes (ACT-T1D). Her research interest is the intersection between type 1 diabetes, metabolic and cardiovascular health, and the role of adjunctive therapies in type 1 diabetes. Active or completed trials include the INTIMET study (metformin), RESET1 (semaglutide), TIRTLE1 (tirzepatide) and TIRTLE2 (tirzepatide).